Forrest W Fearington, Conan Y Zhao, Santiago Romero-Brufau, Eric J Moore, Daniel L Price, Kendall K Tasche, Linda X Yin, Elizabeth T Kunkel, John B Kisiel, Karthik V Giridhar, David M Routman, Kathryn M Van Abel
OBJECTIVES: Blood-based multi-cancer early detection (MCED) tests are now commercially available. However, there are currently no consensus guidelines available for head and neck cancer (HNC) providers to direct work up or surveillance for patients with a positive MCED test. We seek to describe cases of patients with positive MCED tests suggesting HNC and provide insights for their evaluation. METHODS: Retrospective chart review of patients referred to Otolaryngology with an MCED result suggesting HNC...
April 14, 2024: Oral Oncology